Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension Written by Andreas Villaester on 8th June 2022. Posted in Client News. Previous Next